164 related articles for article (PubMed ID: 10909719)
1. [In search of strategies for preventing brain damage as a sequela of bacterial meningitis].
Leib SL; Täuber MG
Schweiz Med Wochenschr; 2000 Jun; 130(24):928-35. PubMed ID: 10909719
[TBL] [Abstract][Full Text] [Related]
2. [Current views on the pathophysiology of bacterial meningitis--new therapeutic possibilities?].
Kepa L
Pol Merkur Lekarski; 1997 Dec; 3(18):291-4. PubMed ID: 9523471
[TBL] [Abstract][Full Text] [Related]
3. Strategies to prevent neuronal damage in paediatric bacterial meningitis.
Grandgirard D; Leib SL
Curr Opin Pediatr; 2006 Apr; 18(2):112-8. PubMed ID: 16601488
[TBL] [Abstract][Full Text] [Related]
4. [Pathophysiology of neuronal injury in bacterial meningitis and experimental adjunctive therapeutic approaches].
Böttcher T
Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S7-9. PubMed ID: 19685399
[TBL] [Abstract][Full Text] [Related]
5. Neonatal bacterial meningitis.
Polin RA; Harris MC
Semin Neonatol; 2001 Apr; 6(2):157-72. PubMed ID: 11483021
[TBL] [Abstract][Full Text] [Related]
6. Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis.
Spreer A; Lugert R; Stoltefaut V; Hoecht A; Eiffert H; Nau R
Crit Care Med; 2009 Jul; 37(7):2253-8. PubMed ID: 19487938
[TBL] [Abstract][Full Text] [Related]
7. Antiinflammatory but no neuroprotective effects of melatonin under clinical treatment conditions in rabbit models of bacterial meningitis.
Spreer A; Gerber J; Baake D; Hanssen M; Huether G; Nau R
J Neurosci Res; 2006 Nov; 84(7):1575-9. PubMed ID: 16998917
[TBL] [Abstract][Full Text] [Related]
8. Emerging drugs for acute bacterial meningitis.
Deghmane AE; Alonso JM; Taha MK
Expert Opin Emerg Drugs; 2009 Sep; 14(3):381-93. PubMed ID: 19624284
[TBL] [Abstract][Full Text] [Related]
9. [Contributions of experimental models to the physiopathology and treatment of bacterial meningitis].
Decazes JM
Rev Prat; 1994 Oct; 44(16):2152-5. PubMed ID: 7984913
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial.
Peltola H; Roine I; Fernández J; Zavala I; Ayala SG; Mata AG; Arbo A; Bologna R; Miño G; Goyo J; López E; de Andrade SD; Sarna S
Clin Infect Dis; 2007 Nov; 45(10):1277-86. PubMed ID: 17968821
[TBL] [Abstract][Full Text] [Related]
11. Nitrogen and oxygen molecules in meningitis-associated labyrinthitis and hearing impairment.
Klein M; Koedel U; Kastenbauer S; Pfister HW
Infection; 2008 Feb; 36(1):2-14. PubMed ID: 18084715
[TBL] [Abstract][Full Text] [Related]
12. Bacterial meningitis: current therapy and possible future treatment options.
Woehrl B; Klein M; Grandgirard D; Koedel U; Leib S
Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1053-65. PubMed ID: 22029523
[TBL] [Abstract][Full Text] [Related]
13. [Value of dexamethasone therapy in bacterial meningitis].
van Wees J; Tegtmeyer KF
Monatsschr Kinderheilkd; 1993 Sep; 141(9):732-5. PubMed ID: 7692244
[TBL] [Abstract][Full Text] [Related]
14. New understandings on the pathophysiology of bacterial meningitis.
Koedel U; Klein M; Pfister HW
Curr Opin Infect Dis; 2010 Jun; 23(3):217-23. PubMed ID: 20216309
[TBL] [Abstract][Full Text] [Related]
15. The chemical biology of clinically tolerated NMDA receptor antagonists.
Chen HS; Lipton SA
J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
[TBL] [Abstract][Full Text] [Related]
16. Experimental models of CNS infections. Contributions to concepts of disease and treatment.
Täuber MG; Brooks-Fournier RA; Sande MA
Neurol Clin; 1986 Feb; 4(1):249-64. PubMed ID: 3523203
[TBL] [Abstract][Full Text] [Related]
17. Glycerol and bacterial meningitis.
Sáez-Llorens X; McCracken GH
Clin Infect Dis; 2007 Nov; 45(10):1287-9. PubMed ID: 17968822
[No Abstract] [Full Text] [Related]
18. Bacterial meningitis after craniocerebral trauma in the community.
Holeckova K; Kolenova A; Lesnakova A; Steno J; Streharova A; Kisac P; Beno P; Kalavsky M; Sramka M; Ondrusova A; Benca J; Seckova S; Sladeckova V; Bartkovjak M; Bukovinova P; Hvizdak F; Lengyel P; Svabova V; Findova L; Kutna K; Deadline J; Johnson MJ; Namulanda V; Juma O; Okoth V; Kovac M; Rudinsky B; Bauer F; Karvaj M; Sabo I; Huttova M; Kenderessy P; Nosko J; Paulikova T; Rusnak R; Povinsky J; Galla S
Neuro Endocrinol Lett; 2007 Nov; 28 Suppl 3():12-3. PubMed ID: 18030265
[TBL] [Abstract][Full Text] [Related]
19. [Is it possible to protect the preterm infant brain and to decrease later neurodevelopmental disabilities?].
Marret S; Foix-L'hélias L; Ancel PY; Kaminski M; Larroque B; Marcou-Labarre A; Laudenbach V
Arch Pediatr; 2008 Jun; 15 Suppl 1():S31-41. PubMed ID: 18822257
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis.
Liu X; Han Q; Sun R; Li Z
Brain Res; 2008 May; 1207():237-43. PubMed ID: 18374903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
